In vitro diagnostics sales will expand through 2036, with reagents holding a 64.0% share of the product segment in 2026. The market is expected to reach USD 94.7 billion in 2026 and USD 151.4 billion by 2036, creating an absolute dollar opportunity of USD 56.7 billion between 2026 and 2036.